Abstract | Iron is an essential trace element for multicellular organisms and nearly all microorganisms. Although iron is abundant in the environment, common forms of iron are minimally soluble and therefore poorly accessible to biological organisms. Microorganisms entering a mammalian host face multiple mechanisms that further restrict their ability to obtain iron and thereby limit their pathogenicity. Iron levels also modulate host defence, as iron content in macrophages regulates their cytokine production. Here, we review recent advances that highlight the role of systemic and cellular iron-regulating mechanisms in protecting hosts from infection, emphasizing aspects that are applicable to human health and disease.
In vertebrates, iron is required as a functional compo nent of many proteins that are involved in a broad range of vital biochemical functions, such as oxygen transport and energy production (TABLE 1) . Iron is also essential for nearly all microorganisms, plants and invertebrate animals, in which it functions as a catalytic component of enzymes that mediate many redox reactions that are crucial for energy production and intermediary meta bolism. Proteins may directly bind to iron or contain iron in the form of haem or iron-sulfur clusters.
Although the modern study of iron homeostasis began more than 80 years ago, a detailed understanding of its molecular basis emerged only in the twentyfirst century and remains incomplete. Nevertheless, early investigators recognized a role for iron regulation in host defence. This led to the concept of irontargeted nutri tional immunity as a set of constitutive and inducible mechanisms that deny iron to invading pathogens and thereby limit their ability to harm the host 1 . In healthy organisms, iron is maintained at a stable concentration in the plasma, and it is stored in hepato cytes and splenic and hepatic macrophages at constant levels, despite a fluctuating supply of iron from the diet. This homeostasis is controlled by an endocrine system that resembles those that regulate glucose and calcium concentrations. Central to systemic iron regulation is the liverderived hormone hepcidin (which is encoded by HAMP), which regulates, and is in turn regulated by, systemic iron levels. The transcription of HAMP is induced by increasing levels of iron in the plasma and in hepatic cellular stores. In turn, by causing degradation of its receptor -the cellular iron exporter ferroportin (also known as SLC40A1) -hepcidin reduces the influx of iron into the plasma from stores and blocks further absorption of dietary iron (FIG. 1) . When body iron levels decrease, hepcidin production is downregulated accord ingly, allowing iron absorption to resume and levels of iron in the plasma to increase.
This feedback loop is disrupted by infection. Infection and inflammation induce hepcidin production, driving a decrease in plasma iron concentrations by inhibiting the absorption of iron and promoting the sequestration of iron in macrophages. Given the absolute dependence of most microorganisms on exogenous iron for their sur vival, it has been assumed that the hypoferraemia of infection and inflammation has a host defence function. Direct evidence of a role for hepcidin and hypoferraemia in host defence is finally being provided by recent studies.
In addition to systemic control by hepcidin, a distinct ironregulatory system maintains iron homeostasis in individual cells, functioning largely independently of systemic regulation. Most cells obtain iron from the extracellular fluid by receptormediated endocytosis of the iron carrier protein transferrin. The levels of trans ferrin receptors and other proteins involved in cell ular iron uptake, storage or use are controlled by iron responsive elementbinding protein 1 (IREBP1; also known as ACO1) and IREBP2 (also known as IREB2). The IREBPs are activated by cellular iron deficiency and bind to the ironresponsive elements (IREs) within mRNAs to regulate mRNA stability or translation. These mechanisms then function to correct cellular iron defi ciency by increasing cellular iron uptake and releasing iron from cytoplasmic ferritin stores.
Macrophages take up large amounts of iron by phagocytosis and through degradation of senescent erythrocytes and other senescent or damaged cells. Within macrophages, phagocytosed iron enters the cytoplasm and can either be stored in ferritin, which is subject to translational regulation by the IREBPs, or be exported to the extracellular fluid through ferroportin. It has been suggested that IREBPs have a role in cellular iron regulation that is important for host defence and during inflammation 2 . However, the local and systemic responses to aseptic inflammation in vivo are preserved in the absence of either of the two IREBPs 3 , which sug gests that the role of the IREBPs in host defence and inflammation is minor or that the two IREBPs have mostly overlapping functions, an issue that needs to be examined further.
During infection, homeostatic mechanisms that store iron within macrophages, scavenge iron in tissues or remove ironcontaining haem and haemoglobin from the circulation are controlled by cytokines. Enhanced iron scavenging and macrophage sequestration seem to have a dual function of denying iron to invading micro organisms and protecting the host from the toxic effects of increased levels of iron, haem and haemoglobin that may be released as a result of tissue damage during infection and inflammation. Not surprisingly, many micro organisms have evolved mechanisms that evade or subvert irontargeted nutritional immunity.
This Review describes the role of the systemic iron homeostatic system in host defence, as supported by human clinical and epidemiological studies, as well as by studies in animal models. We focus on the general mechanisms by which hosts and microorganisms mod ify host iron metabolism during infection and the effects of these changes on the outcome of infection. For more detailed perspectives, the reader is referred to other recent reviews 4, 5 .
Systemic iron homeostasis
Absorption and distribution of iron. Iron is one of the most abundant elements in the Earth's crust, but its oxi dized (ferric) form is largely insoluble and therefore it is poorly absorbed by plants and animals. Accordingly, iron metabolism in vertebrates is characterized by the conservation and recycling of iron. The iron content of the body is maintained by regulating the absorption of iron in the proximal portion of the intestine, the duodenum, to compensate for unregulated iron losses. Obligatory small amounts of iron are lost through the shedding of intestinal and skin cells and minor physio logical blood loss, and larger losses occur through men struation, and bleeding after childbirth or injury. Iron demands are also increased during pregnancy and fetal growth, as well as during childhood growth.
The transfer of absorbed dietary iron into the plasma is mediated by ferroportin on enterocytes in the duo denum. Ferroportin also mediates the export of iron to the plasma from hepatocytes that store iron and from splenic, hepatic and bone marrowderived macrophages that recycle iron from senescent erythrocytes (FIG. 1) .
Intestinal iron absorption and the ironrecycling path way are regulated by hepcidin. Binding of hepcidin to ferroportin causes the endocytosis of ferroportin and diminishes iron export to the plasma from all of its major sources, trapping iron in duodenal enterocytes (which shed into the intestinal lumen after a few days) and in ironrecycling macrophages. Continued use of iron then rapidly depletes the plasma compartment, lowering plasma iron concentration 6 . More than half of the total iron in the body is bound by haemoglobin in erythrocytes, and as much as a quar ter can be present in storage compartments of hepato cytes and macrophages (TABLE 2) . Both ferrous and ferric forms of iron are highly reactive and so their biological forms are chaperoned by proteins or organic chelators. Most of the iron that enters the extracellular fluid is recy cled from senescent erythrocytes and, to a much lesser extent, from other senescent cell types. By contrast, in humans dietary iron absorption normally accounts for only 5% of the influx of iron into the plasma. In the plasma and extracellular fluid, iron is bound to the transport protein transferrin, which has highaffinity ironbinding sites that are normally 20-40% saturated. The plasma contains only 0.1% of the iron content of the body and constitutes a transit compartment that turns over several times a day and functions to deliver iron predominantly to the erythropoietic bone marrow but also to every cell in the body.
Erythropoiesis is particularly sensitive to decreas ing plasma iron concentrations and begins to be inhib ited when the concentrations of transferrinbound iron decrease to levels below its physiological range (10-30 μM). As erythrocytes contain much more iron than other cells and are relatively longlived (120 days in humans), transient inhibition of erythropoiesis during iron scar city may serve to redirect iron to more essential pro cesses. The apparent ability of erythroid precursors to export iron during iron deficiency lends support to this concept 7 . Compared with erythropoiesis, it seems that energy production, intermediary metabolism, neuro behavioural function and host defence (TABLE 1) are spared from the consequences of iron restriction, at least until it becomes very severe.
Regulation of hepcidin. Three major pathophysio logical mechanisms influence hepcidin production: iron and inflammation are stimulatory, and erythropoietin stimulated expansion of erythroid precursors is inhibitory. All pathways regulate hepcidin levels at the level of HAMP transcription, although those used by the erythroid regulator erythroferrone are not well understood.
Regulation of hepcidin by transferrinbound iron con centrations and hepatic iron stores constitutes a feedback mechanism for iron homeostasis (FIG. 1) . The identification of mutations causing genetic iron disorders in humans and studies examining the effects of disrupting these genes in mice have revealed the nonredundant function of the components of the homeostatic pathway. The regu latory loop is centred on the bone morphogenetic protein receptor (BMPR) pathway, which is adapted for iron regu lation by several accessory proteins and iron sensors (FIG. 2 and TABLE 3; for more detail, see . The BMPR is a heterodimer of type I and type II BMPRs that signals predominantly through the SMAD pathway to regulate HAMP transcription. In mice, BMP6 is the BMPR ligand that is required for normal hepcidin production and iron regulation in vivo, but other BMPs also have stimulatory activity in this system. As no genetic disorders that ablate BMP6 in humans have been reported, it is not known whether BMP6 is required for iron regulation in humans. When hepatic iron overload develops, BMP6 production increases and this stimulates hepcidin production and limits further intestinal iron absorption and release of iron from macrophage stores. Although iron accumulates predominantly in hepatocytes, most ironregulated BMP6 seems to be produced by other hepatic cell types (such as sinusoidal endothelial cells, stellate cells and macro phages). The iron sensors and signal transduction path ways by which intracellular iron regulates levels of BMP6 and hepcidin are not known, and their characterization is an important goal for future studies. The glycosylphosphatidylinositol (GPI)linked mem brane protein haemojuvelin (also known as HFE2 and RGMC) is another ironspecific ligand that is required for baseline hepcidin production and for hepcidin and iron regulation. Haemojuvelin interacts with both BMPs and the BMPR, and it is negatively regulated through specific proteolytic cleavage by transmembrane protease serine 6 (TMPRSS6; also known as matriptase 2). Two transferrin receptors -TFR1 (also known as TFRC) and TFR2 -are the likely sensors of the concentration of extracellular transferrinbound iron, and they interact with another ironrelated membrane adaptor protein, HFE, and perhaps also with haemojuvelin to modulate BMPR signalling. Neogenin, a ubiquitous membrane protein, is also essential for ironrelated BMPR signal ling and may function by facilitating the interaction between BMPR, haemojuvelin and TMPRSS6 (REF. 11 ). The molecular interactions of the various components of the ironregulated BMPR complex remain incompletely characterized and are subject to active investigation.
Another set of regulatory factors conveys the iron requirements for erythropoiesis and includes the recently identified hormone erythroferrone 12 , which is produced by erythroblasts in response to erythropoietic stimulation by endogenous or synthetic erythropoietin. Erythroferrone suppresses hepcidin synthesis, making more iron available for enhanced erythropoiesis.
Multiple endocrine stimuli -including testoster one 13 , growth factors (such as epidermal growth factor, hepatocyte growth factor 14 and plateletderived growth factor BB 15 ) and gluconeogenesis 16 -also affect HAMP transcription in hepatocytes, as does endoplasmic retic ulum stress 17, 18 , but the pathophysiological relevance of these pathways is poorly understood.
Another set of regulators of HAMP transcription mediates the effects of host defence and inflammation (FIGS 1,2). Interleukin6 (IL6) is the main cytokine that stimulates hepcidin synthesis during infection 19 and inflammation, but other factors can also contribute, including activin B 20 , type I interferons (IFNs) 21, 22 and 
BMP2 (REF. 23).
Exogenous IL22 increases hepcidin synthesis through an IL6independent mechanism 24, 25 , but the physiological role of IL22 in iron regulation during inflammation has not been reported.
Hepcidin and host defence
Stimulation of hepcidin synthesis during infection. The role of hepcidin as the ironregulatory hormone that acts on ferroportin to modulate iron absorption and systemic iron distribution is now well accepted, but the strong connection between hepcidin and host defence is less well appreciated. Hepcidin was first isolated from human urine and plasma on the basis of its similarity to defensins, which are cationic cysteinerich anti microbial peptides of approximately 3 kDa in size. Hepcidin con centrations, similar to those of certain defensins, are greatly increased during infection and inflammation. Also similar to defensins, hepcidin has direct anti microbial activity in vitro, but the concentrations and conditions required for this activity seem to be outside of the physiological range.
The increase in hepcidin secretion in response to infectious or inflammatory stimuli is responsible for the characteristic hypoferraemia of inflammation 26, 27 , which develops within a few hours of a systemic infection or following injection of microbial components or certain cytokines. High hepcidin concentrations cause iron sequestration in macrophages, which effectively redis tributes iron not only from the plasma compartment but also from nonmacrophage storage in hepatocytes. Prolonged activation of this mechanism during infec tion and inflammation imposes a biological cost in the form of anaemia of inflammation [27] [28] [29] , a condition that is partly caused by the restriction of iron supply to the erythropoietic bone marrow.
Mice engineered to lack hepcidin fail to develop hypo ferraemia after inflammatory stimulation, their serum iron concentrations may even increase during infection or inflammation, and their anaemia of inflammation is milder 28, 29 . Interestingly, although most bacterial and some viral infections (such as influenza virus and HIV) rapidly increase hepcidin production in humans and mouse models, hepatitis B and hepatitis C virus infec tions fail to elicit systemic inflammatory responses and hepcidin production 30 . The consequences of the altered inflammatory and iron responses for infections with these livertropic viruses remain to be determined.
Hepcidin-induced redistribution of iron is protective in malaria.
Malaria infection causes inflammation and increases hepcidin levels, redistributing iron to macro phages and, in the long term, away from hepatocytes that normally support the initial stage of infection. This mechanism may function to prevent superinfection by additional malaria parasites during subsequent expo sures to malariabearing mosquitoes, and it provides a form of innate immune protection in infants and children who have not yet developed an adaptive immune response to malarial parasites 31 .
Hepcidin-induced hypoferraemia and host defence.
It has long been assumed that the hypoferraemia that develops in response to infection or inflammation has a role in host defence against microorganisms that reside in extracellular fluids, but such a function has never been demonstrated and is by no means obvious. Specifically, many pathogenic microorganisms have systems that can effectively scavenge iron, even at low environmental concentrations. During infection, the iron concentration in the plasma may decrease from the normal range of 10-30 μM to as low as 1-3 μM. However, throughout its physiological range of concen trations, the iron remains tightly bound to transferrin, making the iron inaccessible to microbial ferric trans porters. It is therefore not clear how changes in iron concentration would affect microbial iron transport ers, which must function in environments with a wide range of iron concentrations. 
Siderophore
An organic molecule that is synthesized by microorganisms to chelate environmental iron and deliver it for microbial uptake.
Minihepcidins
Synthetic peptides that act as potent hepcidin agonists. Their design is based on the amino-terminal 7-9 amino acid sequence of hepcidin, which is modified to have greater stability, duration of action and potency by substitution of natural for unnatural amino acids and by covalent addition of a fatty or bile acid moiety.
We propose that the hypoferraemic response evolved to provide an increased capacity for trans ferrin to bind iron that would be released during acute infection and during the associated destruction of tis sues and erythrocytes, and so limit the generation of nontransferrinbound iron that can be readily used by many microorganisms. Moreover, nontransferrin bound iron can amplify tissue injury either because it catalyses the extracellular production of injurious reactive oxygen species (ROS) or because it is rapidly taken up some cell types, causing cellular iron overload with the secondary generation of ROS. Exogenous or endogenous hepcidin would be expected to promote the clearance of nontransferrinbound iron that is generated during tissue injury. Indeed, a recent study showed that exogenous hepcidin is protective against renal ischaemia-reperfusion injury and oxidative stress, and that hepcidin deficiency exacerbates these forms of injury 32 . Transferrin, a plasma protein with a halflife of 8-10 days, is recycled when it removes iron that is released from damaged tissues. By contrast, haemopexin and haptoglobin -which are acutephase reactants that scavenge iron complexed in haem and haemoglobin, respectively -are rapidly consumed in the process and must be replaced through augmented synthesis. In chronic infection or inflammation, in which tissue destruction is generally slower, trans ferrin concentrations are somewhat decreased, which effectively raises the concentration of the diferric form, presumably to preserve its delivery to erythroid pre cursors. The consequences of the malfunction of non transferrinbound iron scavenging are revealed in iron overload disorders.
Iron overload disorders and infections
Hereditary haemochromatosis. Hereditary haemo chromatosis is a disease characterized by partial or complete hepcidin deficiency that is caused by genetic lesions in the regulators of HAMP transcription or in the HAMP gene itself 33 . Affected individuals hyper absorb dietary iron and release excessive amounts of iron into the plasma from macrophages, causing trans ferrin saturation to levels that are above its physio logical range (20-45%). Transferrin saturation levels of greater than 80% are prominently associated with the formation of nontransferrinbound iron, which is then rapidly taken up by vulnerable tissues (such as hepatocytes and cardiac myocytes) through alterna tive iron transporters (such as zinc transporter ZIP14 (also known as SLC39A14) in the liver 34 ). Cellular iron overload increases the production of ROS, caus ing cellular injury. Tissue iron overload and resulting toxicity is proportional to the severity and duration of hepcidin deficiency, and results in progressive iron mediated damage to the liver, endocrine glands and cardiac myocytes. Environmental and genetic fac tors -most notably including alcohol consumption and gender -affect the amount of iron overload, especially in the most common form of the disease, which is caused by mutations in HFE that partially preserve hepcidin synthesis 35 .
Iron-loading anaemias. Anaemia owing to ineffective erythropoiesis, as occurs most prominently in patients with β-thalassaemia, is associated with severe iron over load that develops even in the absence of blood trans fusions but is exacerbated in patients who receive repeated transfusions 36, 37 . Despite high concentrations of iron and deposition of iron in the liver and other vital organs, the blood level of hepcidin in untransfused patients with βthalassaemia is very low [38] [39] [40] , owing to suppression by mediators originating from the expanded erythroblast population in the bone marrow 12, 41 . Candidate hepcidin suppressors include erythroferrone and growth and differentiation factor 15 (GDF15), but the pathophysio logical role of these and potentially other relevant mediators remains an active area of study.
Infections associated with genetic iron overload.
Although the relative risk has not yet been estimated, it is clear that patients with hereditary haemochromatosis are predisposed to otherwise rare infections with two Gram negative bacterial species: the marine organism Vibrio vulnificus 42 (and related Vibrio species) and the largely zoonotic bacterium Yersinia enterocolitica 43, 44 . In several reported cases, lethal infections with siderophilic bacteria developed before haemochromatosis was diagnosed [44] [45] [46] . In a particularly poignant case, a researcher with latent hereditary haemochromatosis died rapidly after expo sure to a laboratory strain of Yersinia pestis 45 that was thought to be attenuated because it lacked yersinia bactin, which is a siderophore required for efficient iron uptake. The pathogenicity of similar strains was greatly enhanced in haemochromatotic mice that were gener ated by disruption of the gene encoding either hepcidin or its essential regulator haemojuvelin 47 . Patients with iron overload associated with βthalassaemia are also at increased risk of infection with siderophilic bacteria 48, 49 , as well as other infections, although the evidence for these associations is less conclusive 48, 50, 51 .
Effects of hepcidin expression and hypoferraemia in infection.
Recent studies in hepcidindeficient mice have identified a role for hepcidin in protection from infection with siderophilic bacteria. Hepcidindeficient mice die of sepsis in less than 16 hours after sub cutaneous infection with V. vulnificus at doses that are otherwise well tolerated by wildtype mice 52 . Hepcidin deficient mice are also much more susceptible than wild type mice to death from infection with Y. enterocolitica (D. Stefanova, Y. Bulut, T.G. and E.N., unpublished observations) and certain attenuated strains of Y. pestis 47 . Interestingly, mice infected with siderophilic bacteria were rescued by treatment with potent hepcidin agonists (known as minihepcidins) that induced hypo ferraemia. These treatments had little or no effect on iron stores but redistributed iron from the extracellular space into macrophages. By contrast, systemic iron depletion of hepcidindeficient mice offered only partial protec tion against V. vulnificus, as serum iron concentrations remained high. Susceptibility to death from infection with V. vulnificus correlated with the presence of non transferrinbound iron in the mouse sera and with the ability of sera from these mice to support rapid in vitro growth of V. vulnificus. Ex vivo growth of V. vulnificus in mouse sera was greatly accelerated by the addition of fer ric iron in amounts that exceeded the binding capacity of transferrin 52 . Therefore, we propose that hepcidininduced hypoferraemia functions to limit the availability of non transferrinbound iron during infections. This mechanism is particularly effective against bacterial strains that lack siderophoremediated iron uptake (for example, marine Vibrio species). The paucity of well documented examples of protective effects of reactive hypoferraemia is at odds with the evolutionary conser vation of this mechanism and its obvious biological cost in the form of anaemia of inflammation. It is therefore likely that the protective impact of this mechanism against extracellular microorganisms is much broader than we currently realize.
Paradoxically, studies in mouse models have shown that infections with intracellular microorganisms that reside in macrophages may be enhanced by hepcidin induced iron sequestration, and conversely, hepcidin deficiency in mouse models of hereditary haemo chromatosis may inhibit the growth of macrophage resident bacteria, including Mycobacteria tuberculosis 53 or Salmonella enterica serovar enterica Typhimurium 54 . It has been suggested 55 that increased resistance to intracellular bacteria in individuals homozygous for HFE, and possibly also in those that are heterozygous, led to the high prevalence of HFE mutations in north ern European populations. Although these concepts are supported by experiments with isolated human macrophages and with mouse models, genetic epide miological studies showing the impact of hereditary haemochromatosis on human infections with intracellular microorganisms are lacking.
Iron deficiency and host defence Tropical infections. Iron deficiency is widespread in developing countries and is a major cause of chronic ill ness and loss of economic productivity 56 . In an attempt to address this problem, various means of dietary iron supplementation have been tested. Unfortunately, evi dence is accumulating that indiscriminate iron supple mentation may increase morbidity and mortality from malaria, diarrhoeal illness and tuberculosis [57] [58] [59] . These effects have been attributed to multiple mechanisms: residual iron in the faeces causing changes in the intes tinal flora; stimulation of pathogen growth by increased iron concentrations in plasma or specific organs (as dis cussed in connection with iron overload disorders); or the effects of iron on host defence. The possibility that iron deficiency, which is endemic in tropical regions, may be protective against certain infections has also been raised.
Intestinal flora. Lactic acid bacteria (also known as Lactobacillales) are normal components of the intes tinal flora and have little or no requirement for iron; they thrive in the relatively ironpoor environment of the human intestine, but they may be displaced by other microorganisms when iron is administered 60 . Motivated to understand the connection between iron supplementation and diarrhoeal illness in African chil dren, some but not all studies found an altered composi tion of the intestinal flora and increased inflammation in children who were treated to prevent or reverse iron deficiency [61] [62] [63] .
Protective effects of iron deficiency in malaria.
Following infection, malarial parasites undergo extensive replica tion in hepatocytes, the main cellular site of iron storage. The merozoites then infect erythrocytes -the largest iron compartment in the body -where they continue to multiply. The parasites require iron at both the liver and the erythrocyte stage. During iron deficiency, the liver becomes depleted of stored iron (ferritin), and the erythrocytes become smaller and contain less haemo globin. Epidemiological evidence suggests that iron deficiency is remarkably protective against highgrade parasitaemia and severe malaria 64, 65 , perhaps explaining why more effective iron absorption and storage mecha nisms conferred by haemochromatosis mutations are less common in the tropical regions than in northern Europe. In ex vivo erythrocytes from irondeficient donors, the malarial parasite Plasmodium falciparum invades fewer cells and shows slower intracellular growth than in erythrocytes from ironreplete donors 66 . The protective effect of iron deficiency is reversed by iron supplementation.
Iron deficiency and inflammation.
There is increas ing evidence from mouse models that the macrophage iron depletion seen in iron deficiency, and paradoxi cally also in hereditary haemochromatosis, may have proinflammatory effects 67 . Iron is a required cofactor for enzymes that mediate oxygendependent prolyl and asparaginyl hydroxylation of hypoxiainducible factor 1α (HIF1α), which leads to proteasomal deg radation of this transcription factor. Iron depletion of macrophages could therefore mimic the effects of hypoxia, stabilizing HIF1α and promoting the tran scription and synthesis of IL1β 68 and perhaps other cytokines. IL1β mediates systemic inflammation and activates important host defence mechanisms 69 . A direct hepcidinmediated antiinflammatory effect mediated by ferroportin and the Janus kinase (JAK)-signal transducer and activator of transcrip tion (STAT) pathway was proposed 70 , but JAK-STAT mediated signalling by ferroportin was not confirmed in subsequent moredetailed studies 71 . Although the induction of IL1β is not primarily modulated by hep cidin, hepcidin causes iron sequestration in macro phages (FIG. 3) and would be expected to have an antiinflammatory effect 67 .
Hepcidin-independent iron sequestration Iron-sequestering proteins. In addition to hepcidinthe effects of which on ferroportin cause redistribu tion of iron into macrophages -the tissues and cells of body surfaces and innate immune cells express other molecules that relocate and sequester iron Nature Reviews | Immunology in its various forms and that may function in host defence (TABLE 4) . These include extracellular pro teins, such as lacto ferrin, siderocalin (also known as NGAL or lipocalin 2), haptoglobin and haemopexin, and membraneassociated proteins, such as natural resistanceassociated macrophage protein 1 (NRAMP1; also known as SLC11A1) and TFR1. Lactoferrin is a homologue of the iron carrier protein transferrin but differs from transferrin by continuing to bind iron even at low pH, which is common in inflamed and infected tissues. Siderocalin, a member of a family of proteins that contain a pocket (calyx) for small mostly hydrophobic molecules, binds iron when it is complexed with small natural organic chelators. Haptoglobin and haemopexin are carrier proteins that transport free haemoglobin and haem, respectively, for degradation by macrophages and hepatocytes. NRAMP1 is a ferrous iron transporter found in the membranes of phagocytic vacuoles of macrophages and neutrophils. The concentrations of these iron binding and irontransporting molecules are greatly increased during infection and inflammation, owing to cytokinedriven synthesis (siderocalin, hapto globin and haemopexin are induced by inflammatory cytokines; NRAMP1 is induced by lipopolysaccha ride and IFNγ 72 ) and to degranulation of neutrophils (lactoferrin and siderocalin). By contrast, macrophage expression of TFR1, which mediates iron delivery to endosomes, is decreased by IFNγ exposure during intracellular infections 73 .
Iron sequestration and host defence. Studies in mutant mice have revealed that siderocalin and NRAMP1 have demonstrable nonredundant roles in host defence. The loss of siderocalin in mice causes increased mor tality from septicaemia following infection with Gramnegative bacteria 74 . Mice with a lossoffunction mutation in the divalent metal transporter NRAMP1 show increased susceptibility to specific intracellular infections that target macrophages 72 (TABLE 4) . NRAMP1 variants are associated with an increased risk of tuber culosis in humans 75 , supporting an important contribu tion of this mechanism to resistance against intracellular infections. The specific function of NRAMP1 in phago cytic vacuoles is not definitively understood, but most studies suggest that NRAMP1 transports iron from phagosomes and other vacuoles that contain micro organisms to the cytoplasm of macrophages [76] [77] [78] , thereby starving vacuolar microorganisms of iron.
Microbial countermeasures
Rapid microbial multiplication and clonal selection allow microorganisms to evade conditions that restrict their growth, including iron sequestration by their hosts 79 .
Extracellular bacteria and host ferroproteins. Pathogenic
Gramnegative bacteria (such as Neisseria meningitidis, Neisseria gonorrhoeae and Haemophilus influenzae), which are highly adapted to their human hosts, have evolved specific mechanisms for hijacking various ironcontaining human proteins (such as transferrin, lactoferrin, haemoglobin and ferritin) as a source of iron [80] [81] [82] . The uptake of transferrin by Neisseria species is specific to hominid transferrin, indicating that this spe cialized uptake mechanism facilitates their residence in the human host and several other hominids 83 . Analysis of hominid transferrin sequences and structures has yielded evidence of a mutational 'arms race' between bacterial receptors evolving to bind and take up transferrin as a source of iron, whereas the human Clobe of transferrin, which is targeted by these receptors 84 , has evolved muta tional variants that escape uptake by these bacteria. As an example of another evasive microbial strategy, microor ganisms may modify their siderophores 85 to avoid their sequestration by hostderived siderocalin.
Intracellular microorganisms and the hepcidin-ferroportin system. Hepcidininduced iron sequestration in macrophages (FIG. 3) may paradoxically enhance iron availability for intracellular microorganisms, including Leishmania spp. 86 , Chlamydia spp. and Legionella spp. 87 , as well as S. Typhimurium
88
. S. Typhimurium elicits this response by a mechanism that is dependent on IL6 and oestrogenrelated receptorγ (ESRRγ) 88 . IL6 is increased early in most microbial infections and it stimulates hep cidin transcription via the JAK2-STAT3 pathway in a manner dependent on STAT3binding motifs in the promoter of HAMP (the hepcidin gene) [89] [90] [91] . A recent study 88 indicated that the IL6inducible nuclear recep tor ESRRγ enhances hepcidin induction in response to IL6 in primary hepatocytes. Chemical inhibition of the ESRRγ pathway in a mouse model significantly decreased bacterial burden and modestly improved the survival of infected mice 88 . Although the hepcidinferroportin system seems to function maladaptively during infections with intracellular microorganisms, this host response could be mitigated in infected macrophages by local mechanisms that counteract the systemic effects of hepcidin. Indeed, evidence from mouse models of S. Typhimurium infection suggests that during infections with intracellular microorganisms, the posttranslational downregulation of ferroportin by hepcidin may be opposed by the effects of IFNγ and bacteriastimulated nitric oxide production 92 , which increases transcription of the gene encoding ferroportin (FIG. 3) . NRAMP1 expression is also stimulated by IFNγ 72 , and NRAMP1mediated iron export from phagosomes containing intracellular microorganisms may help to counter the effect of systemic hepcidin. Nevertheless, these mice develop hypoferraemia, indicating that the nitric oxidedependent mechanism operates at a local level and requires the presence of bacteria within the macrophage, leaving most ironrecycling macrophages under the dominant regulatory influence of hepcidin. It remains to be seen whether ferroportin regulation by nitric oxide also occurs in human macrophages, which produce much less nitric oxide than mouse macrophages after activation.
Intracellular microorganisms and erythrophagocytosis.
Erythrocytes are by far the richest source of iron, and therefore residence in erythrophagocytic vacuoles of macrophages might be particularly advantageous for intracellular microorganisms. In chronic infec tion with S. Typhimurium, the bacteria may induce erythrophagocytosis and the conversion of hepatic and splenic macro phages into an M2 phenotype, a process that also requires host signals but has not been charac terized in molecular detail 93 . In this way, these macro phages provide the bacteria with a source of iron from erythro phagocytosis and an M2 macrophage envi ronment with attenuated antimicrobial mechanisms favouring the survival of the bacteria. 
Therapeutic opportunities and challenges
Although targeting iron acquisition in pathogenic microorganisms is an appealing strategy for the treat ment of infection, the design of iron chelators as anti microbial agents is very challenging. An effective iron chelator must be nontoxic, must have higher affinity for ferric iron than bacterial siderophores and must not be recognized by microbial siderophore trans porters 94 . Despite several decades of research in this area that have yielded three successful drugs for the treatment of iron overload disorders, and evidence of in vitro microbistatic activity for several compounds 95 , no chelator has yet been adopted as an antimicrobial therapeutic.
An alternative approach, based on animal models of infection with V. vulnificus or Y. enterocolitica, is the development of socalled minihepcidins, which are small peptide mimetics of hepcidin. These agents were effective against fulminant V. vulnificus infec tion in hepcidindeficient mice 52 . In this model, mini hepcidins rapidly decreased iron concentrations in the plasma and extracellular fluid, and thereby decreased the concentrations of nontransferrinbound iron, which is a likely source of iron for siderophilic bacteria.
Although the logistics of providing these agents to patients with fulminant infections is formidable, mini hepcidins could prove useful in these lethal and often treatmentresistant infections.
Conclusions and perspectives
The scarcity of bioavailable iron has made iron a target of a variety of host defence mechanisms that limit the extent to which microbial invaders can access this essen tial trace metal. In turn, pathogenic microorganisms have evolved mechanisms that counter iron sequestration and allow microbial proliferation within the host. Many aspects of the struggle for iron between microorganisms and their hosts remain unexplained and are important subjects for further research; these include the impact of inflammatory hypoferraemia on common pathogens that are not considered to be siderophilic; understand ing iron availability and its regulation in the subcellular environment of intracellular microorganisms; and com prehensive analysis of the effects of iron deficiency on host defence and inflammation. Finally, the exquisite dependence of most microorganisms on iron provides a rationale for the design of new antimicrobials that target iron uptake mechanisms in pathogenic microorganisms.
